Abbvie CDR (ABBV) ニュース

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 8-K - Current report

AbbVie to Acquire Nimble Therapeutics, Further Strengthening Immunology Pipeline

AbbVie to Acquire Nimble Therapeutics, Further Strengthening Immunology Pipeline PR Newswire NORTH CHICAGO...

AbbVie Completes Acquisition of Aliada Therapeutics

AbbVie Completes Acquisition of Aliada Therapeutics PR Newswire NORTH CHICAGO, Ill., Dec. 11, 2024 Acquisition...

Two Data Analyses From Clinical Trials Show Epcoritamab (DuoBody® CD3xCD20) Induces Durable Complete Reponses As Monotherapy and Combination Treatment in Patients With Diffuse Large B-Cell Lymphoma

Two Data Analyses From Clinical Trials Show Epcoritamab (DuoBody® CD3xCD20) Induces Durable Complete Reponses...

AbbVie Announces Positive Topline Results for the Phase 3 TEMPO-2 Trial Evaluating Tavapadon as a Monotherapy for Parkinson's Disease

AbbVie Announces Positive Topline Results for the Phase 3 TEMPO-2 Trial Evaluating Tavapadon as a Monotherapy...

AbbVie Announces Emotional Impact Report on Mental Health of Underrepresented CLL Cancer Patients

AbbVie Announces Emotional Impact Report on Mental Health of Underrepresented CLL Cancer Patients PR...

Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Therapy Shows High Response Rates in Clinical Trial of Patients With Relapsed or Refractory (R/R) Follicular Lymphoma (FL)

Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Therapy Shows High Response Rates in Clinical...

AbbVie to Present at Citi's 2024 Global Healthcare Conference

AbbVie to Present at Citi's 2024 Global Healthcare Conference PR Newswire NORTH CHICAGO, Ill., Nov. 25, 2024...

Allergan Aesthetics Offers Free Business Education Courses Online to Support Growing Practices with Allergan Aesthetics Products

Allergan Aesthetics Offers Free Business Education Courses Online to Support Growing Practices with Allergan...

AbbVie Receives European Commission Approval of ELAHERE® (mirvetuximab soravtansine) for the Treatment of Platinum-Resistant Ovarian Cancer

AbbVie Receives European Commission Approval of ELAHERE® (mirvetuximab soravtansine) for the Treatment of...

AbbVie Awards 20 Individuals Living With Migraine To Support Career Aspirations

AbbVie Awards 20 Individuals Living With Migraine To Support Career Aspirations PR Newswire NORTH CHICAGO...

AbbVie Provides Update on Phase 2 Results for Emraclidine in Schizophrenia

AbbVie Provides Update on Phase 2 Results for Emraclidine in Schizophrenia PR Newswire NORTH CHICAGO, Ill., Nov. 11, 2024 EMPOWER-1 and EMPOWER-2...

Allergan Aesthetics Celebrates Annual BOTOX® Cosmetic (onabotulinumtoxinA) Day

Allergan Aesthetics Celebrates Annual BOTOX® Cosmetic (onabotulinumtoxinA) Day PR Newswire IRVINE, Calif...